Withus Pharmaceutical Co (330350.KQ) Stock Price
Withus Pharmaceutical Co Price
Revenue has compounded at 9.6% per year over the past 8 years to 106.44 B KRW. Earnings per share have declined at 8.0% per year over the last 8 years. Withus Pharmaceutical Co's net margin stands at 4.7%, down from 7.4% several years earlier. Withus Pharmaceutical Co currently offers a dividend yield of about 1.54%. The payout ratio is around 27% of earnings.
Withus Pharmaceutical Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Withus Pharmaceutical Co business model & stock analysis
Frequently asked questions about Withus Pharmaceutical Co
Converted at the current exchange rate, the Withus Pharmaceutical Co share trades at 4.42 EUR (6,500.00 KRW).
The revenue cannot currently be calculated for Withus Pharmaceutical Co.
The profit cannot currently be calculated for Withus Pharmaceutical Co.
The P/E ratio cannot be calculated for Withus Pharmaceutical Co at the moment.
The P/S cannot be calculated for Withus Pharmaceutical Co currently.
The Eulerpool Quality Score for Withus Pharmaceutical Co is 5/10.
The ISIN of Withus Pharmaceutical Co is KR7330350000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Withus Pharmaceutical Co is 330350.KQ. The ticker symbol is used to trade Withus Pharmaceutical Co shares on the stock exchange.
Withus Pharmaceutical Co stock
Withus Pharmaceutical Co Peer Group
Withus Pharmaceutical Co FIGI
All fundamentals and in-depth analysis of Withus Pharmaceutical Co
Our stock analysis for Withus Pharmaceutical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Withus Pharmaceutical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.